using carbapenems
使用碳青霉烯类
carbapenems are often considered the last line of defense against multidrug-resistant gram-negative bacterial infections.
碳青霉烯类药物通常被视为对抗多重耐药革兰氏阴性菌感染的最后一道防线。
doctors prescribe carbapenems when other antibiotics have failed to treat severe hospital-acquired infections.
当其他抗生素未能治疗严重的医院获得性感染时，医生会开具碳青霉烯类药物。
the increasing prevalence of carbapenem-resistant enterobacteriaceae poses a significant threat to global public health.
耐碳青霉烯肠杆菌科细菌的日益流行对全球公共卫生构成了重大威胁。
meropenem and imipenem are among the most commonly used carbapenems in clinical practice today.
美罗培南和亚胺培南是目前临床实践中最常用的碳青霉烯类药物之一。
patients with a documented penicillin allergy may require careful monitoring when receiving carbapenems.
有青霉素过敏记录的患者在接受碳青霉烯类药物治疗时可能需要仔细监测。
microbiology labs perform specific tests to detect the presence of carbapenemase production in bacterial isolates.
微生物实验室进行特定检测，以确定细菌分离株中是否存在碳青霉烯酶的产生。
the pharmacist reviewed the appropriate dosing of carbapenems for patients with renal impairment.
药剂师审查了肾功能受损患者使用碳青霉烯类药物的适当剂量。
carbapenems exhibit stability against a wide variety of beta-lactamase enzymes produced by resistant bacteria.
碳青霉烯类药物对耐药菌产生的多种β-内酰胺酶表现出稳定性。
inappropriate overuse of carbapenems has accelerated the development of resistance in healthcare settings.
碳青霉烯类药物的不当过度使用加速了医疗机构中耐药性的发展。
ertapenem is a unique carbapenem that can be administered once daily due to its long half-life.
厄塔培南是一种独特的碳青霉烯类药物，由于其半衰期长，可以每日给药一次。
combination therapy is frequently necessary to treat infections caused by carbapenem-resistant organisms.
治疗由耐碳青霉烯类生物引起的感染通常需要联合疗法。
the hospital formulary committee placed restrictions on carbapenems to preserve their efficacy.
医院处方集委员会对碳青霉烯类药物实施了限制，以保持其疗效。
using carbapenems
使用碳青霉烯类
carbapenems are often considered the last line of defense against multidrug-resistant gram-negative bacterial infections.
碳青霉烯类药物通常被视为对抗多重耐药革兰氏阴性菌感染的最后一道防线。
doctors prescribe carbapenems when other antibiotics have failed to treat severe hospital-acquired infections.
当其他抗生素未能治疗严重的医院获得性感染时，医生会开具碳青霉烯类药物。
the increasing prevalence of carbapenem-resistant enterobacteriaceae poses a significant threat to global public health.
耐碳青霉烯肠杆菌科细菌的日益流行对全球公共卫生构成了重大威胁。
meropenem and imipenem are among the most commonly used carbapenems in clinical practice today.
美罗培南和亚胺培南是目前临床实践中最常用的碳青霉烯类药物之一。
patients with a documented penicillin allergy may require careful monitoring when receiving carbapenems.
有青霉素过敏记录的患者在接受碳青霉烯类药物治疗时可能需要仔细监测。
microbiology labs perform specific tests to detect the presence of carbapenemase production in bacterial isolates.
微生物实验室进行特定检测，以确定细菌分离株中是否存在碳青霉烯酶的产生。
the pharmacist reviewed the appropriate dosing of carbapenems for patients with renal impairment.
药剂师审查了肾功能受损患者使用碳青霉烯类药物的适当剂量。
carbapenems exhibit stability against a wide variety of beta-lactamase enzymes produced by resistant bacteria.
碳青霉烯类药物对耐药菌产生的多种β-内酰胺酶表现出稳定性。
inappropriate overuse of carbapenems has accelerated the development of resistance in healthcare settings.
碳青霉烯类药物的不当过度使用加速了医疗机构中耐药性的发展。
ertapenem is a unique carbapenem that can be administered once daily due to its long half-life.
厄塔培南是一种独特的碳青霉烯类药物，由于其半衰期长，可以每日给药一次。
combination therapy is frequently necessary to treat infections caused by carbapenem-resistant organisms.
治疗由耐碳青霉烯类生物引起的感染通常需要联合疗法。
the hospital formulary committee placed restrictions on carbapenems to preserve their efficacy.
医院处方集委员会对碳青霉烯类药物实施了限制，以保持其疗效。
探索常用高频词汇